Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment
about
Complete genome sequence of an M1 strain of Streptococcus pyogenesMolecular Mechanisms of Inhibition of Streptococcus Species by PhytochemicalsStructural features of a zinc binding site in the superantigen strepococcal pyrogenic exotoxin A (SpeA1): Implications for MHC class II recognitionNecrotizing soft tissue infections: review and current concepts in treatment, systems of care, and outcomesIdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G.Epidemiological and Molecular Characterization of an Invasive Group A Streptococcus emm32.2 Outbreak.The M protein is dispensable for maturation of streptococcal cysteine protease SpeB.Six-month multicenter study on invasive infections due to Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilis in Argentina.Structural basis for the recognition of superantigen streptococcal pyrogenic exotoxin A (SpeA1) by MHC class II molecules and T-cell receptors.Post-partum streptococcal toxic shock syndrome associated with necrotizing fasciitis.Characteristics of Streptococcus pyogenes serotype M1 and M3 isolates from patients in Japan from 1981 to 1997.Clindamycin in the treatment of streptococcal and staphylococcal toxic shock syndromes.Chemokine-cleaving Streptococcus pyogenes protease SpyCEP is necessary and sufficient for bacterial dissemination within soft tissues and the respiratory tract.Reciprocal, temporal expression of SpeA and SpeB by invasive M1T1 group a streptococcal isolates in vivo.Mucosal vaccine made from live, recombinant Lactococcus lactis protects mice against pharyngeal infection with Streptococcus pyogenes.Streptococcus pyogenes Ser/Thr kinase-regulated cell wall hydrolase is a cell division plane-recognizing and chain-forming virulence factor.Group A streptococcus--from basic science to clinical disease.Erythromycin-resistant group A streptococcal isolates recovered in Sofia, Bulgaria, from 1995 to 2001A nonpeptide integrin antagonist can inhibit epithelial cell ingestion of Streptococcus pyogenes by blocking formation of integrin alpha 5beta 1-fibronectin-M1 protein complexesComplications of varicella in a defined central European population.Isolation and characterization of a native avirulent strain of Streptococcus suis serotype 2: a perspective for vaccine development.Human pro- and anti-inflammatory cytokine patterns induced by Streptococcus pyogenes erythrogenic (pyrogenic) exotoxin A and C superantigensAcquisition of iron from host proteins by the group A streptococcus.Aspects of eukaryotic-like signaling in Gram-positive cocci: a focus on virulence.Role of mga in growth phase regulation of virulence genes of the group A streptococcus.Molecular diagnosis of necrotizing fasciitis by 16S rRNA gene sequencing and superantigen gene detection.Invasive group A streptococcal infections, clinical manifestations and their predictors, Montreal, 1995-2001.Rapid diagnosis of pharyngitis caused by group A streptococci.Necrotizing fasciitis: pathogenesis and treatment.Regulation of the phosphorylation of human pharyngeal cell proteins by group A streptococcal surface dehydrogenase: signal transduction between streptococci and pharyngeal cells.Molecular Characterization of Invasive Streptococcus dysgalactiae subsp. equisimilis, JapanDefects in ex vivo and in vivo growth and sensitivity to osmotic stress of group A Streptococcus caused by interruption of response regulator gene vicR.Epidemiology of severe Streptococcus pyogenes disease in Europe.Postpartum invasive group A streptococcal disease in the modern era.Bacitracin-resistant clone of Streptococcus pyogenes isolated from pharyngitis patients in Belgium.Rapid increase of resistance to erythromycin and clindamycin in Streptococcus pyogenes in Italy, 1993-1995. The Italian Surveillance Group for Antimicrobial Resistance.Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in EuropeIntravenous immunoglobulin in children with streptococcal toxic shock syndrome.Streptococcal necrotising myositis of obturator internus and piriformis in a type 2 diabetic patient presenting as sepsis of unknown origin.Current insights in invasive group A streptococcal infections in pediatrics.
P2860
Q22066334-3E25BB5A-4774-41B4-B94B-6F24450149FEQ26768465-1D554C6A-5FC8-42EC-82AD-EE94459B73CEQ27631880-C6FA6EF3-007D-4A79-90CD-4C3212BBA977Q28395996-B80A7B6D-433D-4889-83FE-7B1D68934709Q30829613-546FA532-A039-4DBB-ACA3-EC93FC07B5EEQ33721528-CED67C9A-3AE2-4A55-BA98-288A84528ACAQ33793995-D2518054-FD6F-459C-9516-9EC3274AF904Q33824679-EB57D633-9CF0-4C88-8722-19FE631345B1Q33890232-A9E5B769-E2D4-4527-B23F-1D4137AF9A33Q33897063-51F564F3-8D4F-4449-B072-B8319BED6C7FQ33964356-D4E9F2BB-83BE-4733-8BFA-9008EA1FBBD9Q33992560-E5B1525A-0B77-43DB-88ED-8FE312327692Q33996850-8BEC2FDF-F417-4A68-87D3-5F54C31FEE72Q34008621-DE303485-D0DC-4D39-9520-9FBBBCE37DE5Q34145098-4B72225A-A9A0-4824-962D-41A33E58BEAEQ34155390-639B1FA1-3134-438C-8C9C-AD9DE3840F76Q34182521-7A42972B-1661-44BD-8C9B-9BE1C644A2CFQ34202371-C211512B-22A9-471F-A6F5-023853543311Q35082839-483C502D-B21E-4F5F-98E8-1352A162BE51Q35261530-8B1B312D-A9CA-4115-93B4-7178E234998FQ35478867-4272CC18-C54F-4C03-89AD-E2C9835A139BQ35485079-EBC2E9B4-883C-438F-BFD4-7C5454C093CBQ35533007-285B857E-0375-4615-9496-0B4601D40118Q35609664-FF331F80-B9BE-4183-8E26-A2B1A2316C5DQ35628204-BBDEB7A0-03BD-4560-AB1B-2101493B90BCQ35790016-EC5F03DE-F5CB-47B2-A1BB-F8A24C00077DQ35804371-13F60848-6522-471D-8D47-8D308DEFB9A3Q35838596-5FC6E9E0-80BC-44E4-981E-B01F7B232989Q36140694-8AE0879D-061D-4B86-BF68-815B3E6C0006Q36380877-C2121250-26F9-4F98-AA96-E935C7D35B78Q36525251-B712E351-3B9F-4C31-A028-45FC6A31592BQ36711207-3D1C603E-CDE7-449F-9FFE-C1FA3BC22339Q36747672-5EE169DC-7161-48EB-8A75-01156ED850D2Q37034250-2E7D9F5B-3924-4452-A342-9D2F6F60BC9EQ37059093-1D3AF4E0-5ADA-49F8-81F0-1822311919E1Q37091884-DFFF28BB-761D-46D7-B234-EB3E31AB9191Q37156883-974030AA-B011-4890-9EF9-085B7F5EC65CQ37387611-8E39C432-C7AE-497E-B5B7-3B6EA8F06CD2Q37935143-5A5880E1-9950-495B-A3A4-234863034A21Q37988376-0E47F808-591A-43D1-B7C8-A6EA8A3D52B2
P2860
Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment
description
1995 nî lūn-bûn
@nan
1995 թուականին հրատարակուած գիտական յօդուած
@hyw
1995 թվականին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Streptococcal toxic-shock synd ...... and new concepts in treatment
@ast
Streptococcal toxic-shock synd ...... and new concepts in treatment
@en
Streptococcal toxic-shock synd ...... and new concepts in treatment
@nl
type
label
Streptococcal toxic-shock synd ...... and new concepts in treatment
@ast
Streptococcal toxic-shock synd ...... and new concepts in treatment
@en
Streptococcal toxic-shock synd ...... and new concepts in treatment
@nl
prefLabel
Streptococcal toxic-shock synd ...... and new concepts in treatment
@ast
Streptococcal toxic-shock synd ...... and new concepts in treatment
@en
Streptococcal toxic-shock synd ...... and new concepts in treatment
@nl
P2860
P921
P356
P1476
Streptococcal toxic-shock synd ...... and new concepts in treatment
@en
P2093
D L Stevens
P2860
P356
10.3201/EID0103.950301
P407
P577
1995-01-01T00:00:00Z